Journals / Gülhane Tıp Dergisi / 2008 / Cilt: 50 - Sayı: 3

Two female siblings with dilated cardiomyopathy due to primary systemic carnitine deficiency

Primer sistemik karnitin eksikliğine bağlı dilate kardiyomiyopatili iki kardeş

Pages
209–212
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We herein report two female siblings, ten and two years old, who were diagnosed to have dilated cardiomyopathy due to primary systemic carnitine deficiency and whose cardiac functions completely recovered shortly after replacement therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Dilated cardiomyopathy is one of the leading causes of mortality and morbidity of cardiac origin in childhood.
📊
Key Findings & Data:The etiology of pediatric cardiomyopathy remains undetermined in most cases.
💡
Conclusion & Impact:We herein report two female siblings, ten and two years old, who were diagnosed to have dilated cardiomyopathy due to primary systemic carnitine deficiency and whose cardiac functions completely recovered shortly after replacement therapy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kardiyografi · empedans · Karnitin

Abstract

Dilated cardiomyopathy is one of the leading causes of mortality and morbidity of cardiac origin in childhood. The etiology of pediatric cardiomyopathy remains undetermined in most cases. Some of dilated or hypertrophic cardiomyopathies with early onset may be due to primary systemic carnitine deficiency and give good response to replacement therapy. We herein report two female siblings, ten and two years old, who were diagnosed to have dilated cardiomyopathy due to primary systemic carnitine deficiency and whose cardiac functions completely recovered shortly after replacement therapy.

Özet

Dilate kardiyomiyopati, çocukluk çağında kardiyak nedenli morbidite ve ölümün önde gelen nedenlerinden birisidir. Çocuk yaş grubunda kardiyomiyopatilerin önemli bir bölümünde neden bulunamamaktadır. Erken başlangıçlı dilate veya hipertrofik kardiyomiyopatilerin bir bölümü primer sistemik karnitin eksikliğinden kaynaklanmakta ve replasman tedavisine çok iyi yanıt vermektedir. Burada primer sistemik karnitin eksikliğine bağlı dilate kardiyomiyopati tanısı konulan, replasman tedavisi ile kardiyak fonksiyonları kısa sürede düzelen on ve iki yaşında iki kız kardeş sunulmaktadır.

🔖

Cite This Article

OKUTAN, V., YOZGAT, Y., AYDIN, H. İ., YAVUZ, S., LENK, M. K. (2008). Two female siblings with dilated cardiomyopathy due to primary systemic carnitine deficiency. Gülhane Tıp Dergisi, Cilt: 50 - Sayı: 3, 209–212. https://ajindex.com/articles/226181

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Olson TM, Chan DP. Dilated congestive cardiomyopathy. In: Allen HD, Clarck EB, Gutgesell HP, Driscoll DJ (eds). Moss and Adams’ Heart Disease in Infants, Children and Adolescents Including the Fetus and Young Adult. 6th ed. Vol 2. Philadelphia: Lippincott Williams&Wilkins, 2001: 1187-1196
  2. Kasper EK, Agema WRP, Hutchins GM, et al. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 1994; 23:586-590
  3. Winter SC, Jue K, Prochazka J, et al. The role of Lcarnitine in pediatric cardiomyopathy. J Child Neurol 1995; 2: 45-51
  4. Kinali M, Olpin SE, Clayton PT, et al. Diagnostic difficulties in a case of primary systemic carnitine deficiency with idiopathic dilated cardiomyopathy. Eur J Pediatr Neurol 2004; 8: 217-219
  5. Oh JK, Seward JB, Tajik JA. Assessment of ventricular systolic function. In: Oh JK, Seward JB, Tajik JA (eds). The Echo Manual. 2nd ed. Minnesota: Lippincott Williams&Wilkins, 1999: 37-43
  6. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med 1994; 330: 913-919
  7. Neely JR, Morgan HA. Relationship between carbohydrate metabolism and energy balance of heart muscle. Ann Rev Physiol 1974; 36: 413-459
  8. Bremer J. Carnitine-metabolism and functions. Physiol Rev 1983; 63: 1421-1480
  9. Tokatlı A. Metabolik kardiyomiyopatiler. Katkı Pediatri Dergisi 2001; 22: 76-98
  10. Tripp ME, Katcher ML, Peters HA, Gilbert EF, Hodach RJ, Shug AL. Systemic carnitine deficiency presenting as familial endocardial fibroelastosis. N Engl J Med 1981;305: 385-390
  11. Waber LJ, Valle D, Neill C, Di Mauro S, Shug A. Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport. J Pediatr 1982;101: 700-705
  12. Christensen E, Vikre-Jorgensen J. Six years experience with carnitine supplementation in a patient with an inherited defective carnitine transport system. J Inherit Metab Dis 1995; 18: 233-236
  13. Rebouche CJ, Paulson DJ. Carnitine metabolism and functions in humans. Ann Rev Nutr 1986; 6: 41-66
  14. Lamhonwah AM, Tein I. Carnitine uptake defect: frameshift mutations in the human plasmalemmal carnitine transport gene. Biochem Biophys Res Commun 1998; 252: 396-401
  15. Wang Y, Ye J, Ganapathy V, Longo N. Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. Proc Natl Acad Sci USA 1999; 96:2356-2360
  16. Pierpont MEM, Breningstall GN, Stanley CA, Singh A. Familial carnitine transporter defect: a treatable cause